TEVA FY 2016 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$21.9B+11.5% YoY

Gross Profit

$11.9B54.1% margin

Operating Income

$2.2B9.8% margin

Net Income

$329M1.5% margin

EPS (Diluted)

$0.07

Cash Flow

Operating Cash Flow

$5.2B

Free Cash Flow

$4.3B

Stock-Based Comp.

$124M

Balance Sheet

Total Assets

$92.9B

Total Liabilities

$57.9B

Stockholders' Equity

$33.3B

Cash & Equivalents

$988M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21.9B	$19.7B	+11.5%
Gross Profit	$11.9B	$11.4B	+4.4%
Operating Income	$2.2B	$3.4B	-35.7%
Net Income	$329M	$1.6B	-79.3%